國家衛生研究院 NHRI:
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 854069      Online Users : 1451
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version

    Collection

    Patents [0/23]
    Periodical Articles [37/38]
    Conference Papers/Meeting Abstract [4/5]

    Community Statistics


    Item counts issued in 3 years:0(0.00%)
    Items With Fulltext:41(62.12%)

    Download counts of the item
    Download times greater than 0:41(100.00%)
    Download times greater than 100:41(100.00%)
    Total Bitstream Download Counts:30879(0.58%)

    Last Update: 2024-11-28 17:44

    Top Upload

    Loading...

    Top Download

    Loading...

    RSS Feed RSS Feed
    Jump to a point in the index:
    Or type in a year:
    Ordering With Most Recent First Show Oldest First

    Showing items 51-66 of 66. (3 Page(s) Totally)
    << < 1 2 3 
    View [10|25|50] records per page

    DateTitleRelation
    2009-06 A three-dimensional pharmacophore model for dipeptidyl peptidase IV inhibitiors [Erratum: European Journal of Medicinal Chemistry. 2008 Aug;43(8):1603-1611.] European Journal of Medicinal Chemistry. 2009 Jun;44(6):2763-2763.
    2009-04-01 Rational design and synthesis of potent and long-lasting glutamic acid-based dipeptidyl peptidase IV inhibitors Bioorganic and Medicinal Chemistry Letters. 2009 Apr 1;19(7):1908-1912.
    2009-03-15 Novel trans-2-aryl-cyclopropylamine analogues as potent and selective dipeptidyl peptidase IV inhibitors Bioorganic and Medicinal Chemistry. 2009 Mar 15;17(6):2388-2399.
    2009-01-22 Pyrrolidine compounds AU2005221678/2009-01-22
    2008-09-16 Pyrrolidine compounds US7425633B2/2008-09-16
    2008-08 A three-dimensional pharmacophore model for dipeptidyl peptidase IV inhibitors European Journal of Medicinal Chemistry. 2008 Aug;43(8):1603-1611.
    2008-07-21 吡咯啉啶化合物 I299039/2008-07-21
    2008-07-01 Pyrrolidine compounds KR10-0844593/2008-07-01
    2007-03-01 3-[2-((2S)-2-Cyano-pyrrolidin-1-yl)-2-oxo-ethylamino]-3-methyl-butyramide analogues as selective DPP-IV inhibitors for the treatment of type-II diabetes Bioorganic and Medicinal Chemistry Letters. 2007 Mar;17(5):1274-1279.
    2006-09 MEDI 416-3- 2-((2S)-2-Cyano-pyrrolidin-1-yl)-2-oxo-ethylamino -3-methyl-butyr amide analogs as DPP-IV inhibitors for the treatment of type-II diabetes Abstracts of Papers - American Chemical Society. 2006 Sep;232:MEDI 416.
    2006-06-15 Substituted pyrrolidine-2,4-dicarboxylic acid amides as potent dipeptidyl peptidase IV inhibitors Bioorganic and Medicinal Chemistry Letters. 2006 Jun;16(12):3268-3272.
    2006-01-12 2-[3-[2-[(2S)-2-cyano-1-pyrrolidinyl]-2-oxoethylamino]-3-methyl-1-oxobutyl]-1,2,3,4-tetrahydroisoquinoline: A potent, selective, and orally bioavailable dipeptide-derived inhibitor of dipeptidyl peptidase IV Journal of Medicinal Chemistry. 2006 Jan;49(1):373-380.
    2005-07-01 Glutamic acid analogues as potent dipeptidyl peptidase IV and 8 inhibitors Bioorganic and Medicinal Chemistry Letters. 2005 Jul;15(13):3271-3275.
    2005-04-15 Benzothiazolium compounds: Novel classes of inhibitors that suppress the nitric oxide production in RAW264.7 cells stimulated by LPS/IFN gamma Bioorganic and Medicinal Chemistry Letters. 2005 Apr;15(8):2027-2032.
    2005-02-01 Novel isoindoline compounds for potent and selective inhibition of prolyl dipeptidase DPP8 Bioorganic and Medicinal Chemistry Letters. 2005 Feb;15(3):687-691.
    2004-11 Novel classes of inhibitors that suppress the nitric oxide production in RAW264.7 cells stimulated by LPS and IFN gamma Molecular Biology of the Cell. 2004 Nov;15(Suppl.S):497A.

    Showing items 51-66 of 66. (3 Page(s) Totally)
    << < 1 2 3 
    View [10|25|50] records per page

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback